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Phagocytosis is a key process in protection of the host against pathogens
and in provision of antigens for the immune response. Synergism between
C3b and IgG and their receptors in promoting adherence to and then ingestion of an antigen has been recognized for decades. Only more recently,
however, has cross-talk between another complement activation fragment,
the anaphylatoxin C5a, and Fcγ receptors (FcγRs) been defined. In this
issue of the JCI, C5a is shown to signal, via its receptor, the upregulation of
activating (proinflammatory-type) FcγRs (see the related article beginning
on page 512). Moreover, engagement of FcγRs by the IgG-bearing immune
complex instructs the cell to synthesize more C5, from which C5a is derived.
Thus, this work establishes a feedback loop whereby FcγR expression and
function are enhanced, a very desirable event in concert with an infection
but potentially deleterious in autoimmunity.
0QTPOJ[BUJPOIFMQJOH
QIBHPDZUFTUPFBU
Opsonins attach to invading microorganisms and other antigens in order to
enhance the uptake of foreign particles by
phagocytes. The 2 most important opsonins in blood are Ig and complement (C).
Specifically, IgG and C3b bind to a target
where they serve as ligands for Fcγ and C
receptors, respectively. This reaction can
be conveniently split into 2 sequential
steps; namely, immune adherence followed by internalization. Early on, it was
Nonstandard abbreviations used: C, complement;
C5aR, C5a anaphylatoxin receptor; FcγR, Fcγ receptor.
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recognized that C3b and C receptors most
effectively mediated the adherence step,
while Fcγ receptors (FcγRs) most effectively mediated the internalization step. This
combination of “talents” ensures efficient
phagocytosis of an infectious particle. As
the humoral immune response rapidly
matures, it deposits more and more IgG
on particles, which subsequently elicits
complement activation.
Many types of in vivo and in vitro experiments have demonstrated how much more
proficient C3b and IgG are as partners
than either is alone in promoting phagocytosis. C3b can mediate internalization but
requires a relatively large ligand load and
activated monocytes/macrophages. IgG
can mediate adherence, but again, a heavy
dose of ligand is necessary. However, a com-
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bination of C3b and IgG is synergistic in
mediating the phagocytic process. Thus,
this cooperation between the receptors for
these 2 ligands enhances this time-honored immune phenomenon that is critical
to survival. In this issue of the JCI, Kumar,
Gessner, and colleagues provide further
evidence for another remarkable interaction among complement-derived ligands,
Igs, and their receptors (1).
$SPTTUBMLCFUXFFO$BBOE'Dγ3T
Kumar et al. (1) report a clear demonstration of cross-talk between the C and Ig
receptors (Figure 1 and Table 1). In a mouse
model of a so-called antibody-dependent,
type II autoimmune reaction, the authors
convincingly demonstrate the following
interesting sequence of events: (a) upon
injection of an autoantibody to mouse
rbcs, immune complexes form that bind to
FcγRs on liver macrophages (Kupffer cells);
(b) these cells in turn secrete C5 and possibly a protease (yet to be clearly defined)
that cleaves C5 into the anaphylatoxin
C5a and the initiator of membrane attack
complex, C5b; (c) C5a binds to its receptor
(C5aR) on Kupffer cells, which upregulates
FcγR mRNA expression; and then (d) the
increased number of FcγRs on these macrophages facilitates elimination of the
antibody-coated rbcs, thereby leading to a
more severe hemolytic anemia. While this
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this is straightforward but not appreciated
or commented upon by most investigators.
C5, like many complement components,
may be synthesized locally by monocytes/
macrophages and other cell types, where it
can be cleaved by proteases to produce C5a.
This type of complement activation does not
rely on any 1 of 3 pathways (classical, lectin,
or alternative). A lack of appreciation for
this possibility has led other investigators to
mistakenly rule out an effect of the complement system, including those mediated by
the upregulation of FcγRs following C5aR
engagement (4, 5). C5 and C5aR knockout
animals must be examined before a role for
the complement system can be excluded.
'FFECBDLMPPQUPFOIBODF
'DγFYQSFTTJPO
Specifically, the 3 reports from the Gessner group establish a feedback loop via
'JHVSF
cross-talk between 2 receptors (Figure 1).
5IFJOUFSBDUJPOTBNPOH$BBOE*H(BOEUIFJSSFDFQUPST)VNPSBMBVUPJNNVOJUZJTJMMVTUSBUFE
The
early engagement of FcγR sends a sig"O*H(SFTQPOTFIBTCFFONBEFUPBOBOUJHFOPOUIFTVSGBDFPGFSZUISPDZUFT*H(CJOETUPUIJT
BOUJHFOUPGPSNJNNVOFDPNQMFYFT4VDIJNNVOFDPNQMFYFTDBOCPUIJOUFSBDUXJUI'Dγ3BOE nal to macrophages to provide a source of
BDUJWBUFUIFDPNQMFNFOUTZTUFN5IF'Dγ3TJHOBMTUIFDFMMUPJODSFBTF$TZOUIFTJT SFTVMUJOH C5 from which C5a can be generated. C5a,
JONPSF$B XIJDIJOUVSOGFFETCBDLUISPVHIJUTSFDFQUPSUPVQSFHVMBUF'Dγ3FYQSFTTJPO
through its receptor, in turn signals the cell
to synthesize more FcγRs. The signal has
specificity, as expression of the activating
process is designed to “rev up” immune or C and its receptors, most IgG-mediated (proinflammatory) FcγRI and FcγRIII recepclearance in the setting of an infection by events require FcγR engagement and com- tors is upregulated, while expression of the
splenic and hepatic macrophages (once plement activation. Moreover, these events inhibitory FcγRII receptor is either downknown as the reticuloendothelial system), are commonly additive, if not synergistic, modulated or unchanged. Many investigait will of course also play out in immuno- and, in many cases, interdependent. The tors have previously shown that “activated”
animal species, site of inflammation, anti- macrophages, with their increased suppathologic syndromes.
These data (1) are not the first to suggest body types mediating the response, cellular ply of FcγRs and other accoutrements, are
this intriguing connection between C5a location of receptors, and many other fac- more efficient at immune clearance and
and FcγR. In 2 prior publications, includ- tors contribute to such immune responses. phagocytosis than resting cells (6). So, in
ing one in the JCI, this same group estab- The issue is not necessarily one of “my sys- many respects, these studies re-establish
lished that C5a initiates inflammation tem is more important than yours,” but the importance of macrophage activation
through its effects on FcγRs and through rather one of an improved definition of in the destruction of antibody- and C-tarits more direct role as a cell activator and the timing, interactions, and synergies that geted antigens. While this feedback event
chemoattractant (2, 3). In the 2002 study, mediate a given response. This understand- was established in an animal model of paswhich used an acute immune complex ing has now been nicely demonstrated by sive transfer of an autoantibody, its physipulmonary hypersensitivity model (2), Gessner and colleagues in the current ological role is to more efficiently eliminate
C5aR engagement led to an increase in study (1) and summarized by Gessner and bacteria and viruses from the bloodstream.
number and enhanced function of activat- Schmidt in a recent review (4).
There is much yet to be learned about the
An important point is that the use of C3- intracellular pathways in these signaling
ing FcγRs (FcγRIII) versus the inhibitory
FcγRs (FcγRII) on alveolar macrophages. deficient mice would not have been suffi- events and the control of this process.
A few caveats about the authors’ model
If these changes did not occur, such as cient to rule out a role for complement in the
in C5aR-deficient animals, cytokine pro- studies by Kumar et al. (1). The reason for system (1) should be mentioned. The invesduction and neutrophil recruitment were
impaired. In the more recent report (3),
5BCMF
which used a similar model, but this time
Consequences of C5aR engagement for FcγRs
in the peritoneum of mice, C5aR activation was necessary to initiate neutrophil
recruitment and to instruct a proinflammatory FcγR response.
While immune models can be set up to
demonstrate that certain immunopathologic conditions require only IgG and FcγR,

1. ↑ in FcγRI expression
2. ↑ in FcγRIII expression

Activating or proinflammatory receptors

3. No change or ↓ in FcγRII expression

Inhibitory receptor

3FTVMUT"VHNFOUFE'Dγ3OVNCFSBOEGVODUJPO XIJDIJTEFTJSBCMFJOJOGFDUJPOTCVUVOEFTJSBCMFJO
IVNPSBMBVUPJNNVOJUZ
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tigators injected a single, large dose of an
autoantibody that recognizes mouse rbcs to
generate their cross-talk model system. The
quantity of antibody used decreased the
hematocrit from 50% to 25% in 4 days, even
in FcγR–/– animals. Thus, C activation and
rbc destruction took place via intravascular
lysis and receptor-mediated extravascular
sequestration (7). Complement activation
occurs rapidly (within seconds) in this model
and would provide another source of C5a to
enhance FcγR mRNA expression; this may be
the most likely C5a source in vivo. Second,
the authors do not establish the mechanism
for generating C5a. They hypothesize that a
protease cleaves C5. Third, while they demonstrate upregulation of FcγRI and FcγRIII
mRNA expression, they do not document an
increased number of FcγRs on Kupffer cells
in vitro or in vivo. Fourth, the authors nicely
establish that FcγRII (the FcγR that sends a
negative or antiinflammatory signal) plays
no role in their observations. The reason
here is simple: Kupffer cells do not express
this receptor, although FcγRII was expressed
on sinusoidal cells.
*NNVOPQBUIPMPHJDSFBDUJPOT
As a final comment, in their study, Kumar
et al. (1) refer to their model as an anti-

body-dependent type II autoimmune reaction. Antibodies of this type are directed
at cell-bound targets (in the case of autoimmune hemolytic anemia) or matrix
proteins (in the case of Goodpasture syndrome). The most up-to-date immunology textbooks still all have tables showing the Gell and Coombs classification
system of immunopathologic reactions
(8). I first learned about this system, as
did many aspiring immunologists of my
generation, at the NIH, where we were so
fortunate to have Bill Paul as our teacher
in the immunology course. I have now
been teaching this same classification system for 30-plus years to students at Washington University School of Medicine.
Students and senior immunologists still
find it a useful scheme to classify immune
reactions that we would like to be able to
better control. Hopefully, insights provided by studies like those of Gessner’s
group will eventually provide us with the
tools to accomplish this goal.
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Mucous hypersecretion is a major cause of airway obstruction in asthma,
chronic obstructive pulmonary disease, and cystic fibrosis. EGFR ligands
and IL-13 are known to stimulate mucous induction, but the detailed mechanisms of epithelial mucous regulation have not been well defined. In this
issue of the JCI, Tyner et al. show, in a mouse model of chronic mucous
hypersecretion, that ciliated epithelial cell apoptosis is inhibited by EGFR
activation, allowing IL-13 to stimulate the differentiation of these cells into
goblet cells, which secrete mucus (see the related article beginning on page
309). In defining this coordinated, 2-step process, we can consider the therapeutic effects of blocking mucous production. This begs the question, Is it
possible to reduce airway obstruction in chronic lung disease by inhibiting
EGFR activation and/or by inhibiting IL-13?
Nonstandard abbreviations used: COPD, chronic
obstructive pulmonary disease.
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In the respiratory tract, mucus is a critical
component of the innate host defense system. On the airway epithelial cell surface,
the sticky gel layer traps particles and the
sol layer, which is predominantly water, contacts the surface of ciliated cells and permits
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moving of the gel out of the lower airways
like an escalator so that it can ultimately be
cleared by coughing or swallowing. Mucus
also contains antibacterial agents to aid in
its defense function. Pathogens and harmless proteins we inhale are thus removed
from the respiratory tract and have a limited
encounter with other immune components.
In the bronchial airways, mucus is produced
by surface epithelial cells with secretory features and a classical goblet shape, called
goblet cells. Goblet cells produce mucins
that are complexed with water in secretory
granules and are released into the airway
lumen. In the large airways, mucus is also
produced by mucous glands. Under basal
conditions, the columnar epithelial surface
comprises a small percentage of goblet cells
and a majority of ciliated cells. This struc-
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